KFF and the Peterson Center on Healthcare examine market trends contributing to rising health costs and identify several potential federal and state policy issues to watch throughout 2025, including high-cost drugs, federal funding cuts, and workforce shortages.
As we look toward the new year, a key step is bringing together stakeholders to better understand how burnout can affect a person’s ability to engage in self-care and collaborative care — and how to develop proactive, person-centered solutions that get to the root causes of distress before they lead to detrimental disengagement. The post…
Seaport Therapeutics’ Series B financing was one of the largest rounds of funding in our recap of biotech financing news, which spans startups developing drugs for neurological diseases, cancer, immunology, and more. The post Seaport Therapeutics Secures $225M for New Kind of Depression Drug appeared first on MedCity News.
On the campaign trail, both former President Donald Trump and Vice President Kamala Harris are eager to portray themselves as guardians of Medicare. Each presidential candidate accuses the other of backing spending cuts and other policies that would damage the health insurance program for older Americans. But the election’s outcome could alter the very nature…
Applications of SandboxAQ’s large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022. The post AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More appeared first on MedCity News.
Investing in strategic healthcare communications is not just good marketing, it is essential for organizations that want to restore trust and improve patient outcomes. The post The Role of Marketing in Building Trust Between Providers and Patients appeared first on MedCity News.
Response Pharmaceuticals takes a new approach to weight loss with an oral small molecule designed to inhibit a protein called iMTP to reduce uptake of fats and cholesterol. While this drug’s lead indication is addressing weight gain in patients taking antipsychotics, the company is also exploring other metabolic indications such as patients who need a…
The One Big Beautiful Bill Act introduced a new $50 billion fund to offer rural hospitals a financial lifeline. One expert cautions that this effort will fail to address systemic challenges without transparency, clear metrics and long-term infrastructure investment strategies. The post Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short appeared first…
Penn researchers have received funding from Advanced Research Projects Agency for Health (ARPA-H) to focus on breast cancer, heart attacks and sepsis
It has become standard practice for healthcare organizations to focus on identifying and stopping external threats to the privacy and security of data, but one often overlooked risk may be right inside your offices — snooping employees and malicious insider threats. The post User Activity Monitoring: Real-Time Visibility Within the EHR to Stay Ahead of…